Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Wednesday, 02'nd Apr 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
08:44am, Wednesday, 02'nd Apr 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson &
3 Wide-Moat Dividend Stars For A Championship Portfolio
07:30am, Wednesday, 02'nd Apr 2025
I linked investing to baseball, showing how consistency, like the A's Moneyball approach, wins long term. Steady dividend growers and low-volatility stocks outperform, especially in rocky markets. Top
S&P 500 Gains and Losses Today: Johnson & Johnson Drops as Judge Rejects Liability Settlement
05:31pm, Tuesday, 01'st Apr 2025
Major U.S. equities indexes finished the first trading day of the second quarter mixed.
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
04:06pm, Tuesday, 01'st Apr 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that following the approval of its pending acquisition of Intra-Cellular Therapies, Inc. by Intra-Cellular Therapies
Why Johnson & Johnson Stock Is Sinking Today
02:38pm, Tuesday, 01'st Apr 2025
Shares of Johnson & Johnson (JNJ -6.57%) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m.
S&P, Nasdaq rise as investors await US tariff clarity; Johnson & Johnson slips, PVV Corp jumps
01:08pm, Tuesday, 01'st Apr 2025
The S&P 500 experienced volatility on Tuesday and was in the green. Investors were awaiting clarity from US President Donald Trump regarding tariff policy, and weaker-than-expected economic data also
Dogs Of The Dow Chase April's 'Safer' Buy
12:05pm, Tuesday, 01'st Apr 2025
Verizon is the only Dow Dog currently meeting the ideal of annual dividends from $1K invested exceeding its single share price. Analysts forecast net gains of 13.06% to 37.60% for the top-ten Dow Dogs
Johnson & Johnson shares fall as US judge rejects $10B talc settlement plan
11:24am, Tuesday, 01'st Apr 2025
Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal which sought to resolve tens of thousands of lawsuits alleging its ta
Judge rejects Johnson & Johnson's $10B settlement to end baby powder lawsuits
10:47am, Tuesday, 01'st Apr 2025
A judge rejected Johnson & Johnson's $10 billion proposal to end tens of thousands of lawsuits alleging that its products caused ovarian cancer.
J&J's Third Bankruptcy Attempt to End Talc Suits Rejected
10:30am, Tuesday, 01'st Apr 2025
J&J fails in its third attempt to settle tens of thousands of lawsuits claiming its talc-based powder caused cancer.
J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
10:18am, Tuesday, 01'st Apr 2025
Johnson & Johnson stock slumped Tuesday after a judge rejected its $10 billion proposal to settle thousands of talc-tied lawsuits. The post J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bank
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
09:29am, Tuesday, 01'st Apr 2025
HOUSTON--(BUSINESS WIRE)--In a resounding victory for thousands of women who have suffered from ovarian cancer linked to Johnson & Johnson's (NYSE:JNJ) talcum powder products, U.S. Bankruptcy Court Ju
Johnson & Johnson Latest Talc Resolution Rejected. The Stock Is Falling.
08:15am, Tuesday, 01'st Apr 2025
A bankruptcy judge in Texas rejected a proposal that would have ended most lawsuits saying the products cause ovarian cancer.
J&J shares fall after judge rejects $10 billion talc settlement
07:11am, Tuesday, 01'st Apr 2025
Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc
